Chene Gautier, Chauvy Lauriane, Buenerd Annie, Moret Stéphanie, Nadaud Béatrice, Chabert Philippe, Lamblin Gery
Department gynecology, Hôpital Femme Mère Enfant, HFME, Lyon CHU, Lyon, France; Université Claude Bernard Lyon 1, EMR 3738, 69000 Lyon, France.
Department gynecology, Hôpital Femme Mère Enfant, HFME, Lyon CHU, Lyon, France.
Eur J Obstet Gynecol Reprod Biol. 2017 Sep;216:18-23. doi: 10.1016/j.ejogrb.2017.07.002. Epub 2017 Jul 5.
Recently it has been postulated that most ovarian cancers have a tubal origin. The identification of preinvasive tubal lesions would be of great interest in the early diagnosis of ovarian cancer. Optical biopsy has been developed and validated in the detection of precancerous lesions (such as Barrett's oesophagus). The first objective of this study was to assess the feasibility of optical biopsy in the study of fallopian tubes during laparoscopy. The second objective was to describe the images in benign premalignant and malignant tubes with a histopathological and immunohistochemical (p53 and Ki67 expressions) correlation.
In this prospective study, 40 patients undergoing laparoscopic salpingectomy for benign conditions (benign hysterectomy), prophylactic conditions (BRCA mutation) or in case of pelvic cancers were included after obtaining informed and signed consent prior to surgery. The optical biopsy was performed on the fimbria of each tube in and ex vivo. A correlation was made with the histopathological and immunohistochemical analysis.
The feasibility of optical biopsy was always confirmed during laparoscopy. The optical biopsy iconography revealed different images in benign tubal epithelium (well-defined black and grey structure), in adenomatoid tumour (tortuous architectural organization), in STIC precancerous lesion (enlarged, irregular and pleomorphic cells, dilated and distorted vessels) and in tubal metastasis of high grade serous ovarian cancer (dark neoplastic cells irregular in size and shape) CONCLUSIONS: Optical biopsy may be the first emerging mini-invasive technology that could detect tubal lesions and may be considered as a promising tool in the early detection of ovarian cancer.
最近有人提出,大多数卵巢癌起源于输卵管。识别输卵管的癌前病变对于卵巢癌的早期诊断具有重要意义。光学活检已在癌前病变(如巴雷特食管)的检测中得到开发和验证。本研究的首要目标是评估腹腔镜检查期间对输卵管进行光学活检的可行性。第二个目标是描述良性、癌前和恶性输卵管的图像,并与组织病理学和免疫组织化学(p53和Ki67表达)进行相关性分析。
在这项前瞻性研究中,40例因良性疾病(良性子宫切除术)、预防性情况(BRCA突变)或盆腔癌而接受腹腔镜输卵管切除术的患者在手术前获得知情并签署同意书后被纳入研究。对每根输卵管的伞端进行体内和体外光学活检。并与组织病理学和免疫组织化学分析进行相关性分析。
腹腔镜检查期间始终证实了光学活检的可行性。光学活检成像显示良性输卵管上皮(边界清晰的黑色和灰色结构)、腺瘤样肿瘤(曲折的结构组织)、STIC癌前病变(细胞增大、不规则且多形,血管扩张和扭曲)以及高级别浆液性卵巢癌的输卵管转移(大小和形状不规则的深色肿瘤细胞)呈现出不同的图像。结论:光学活检可能是第一种能够检测输卵管病变的新兴微创技术,可被视为早期检测卵巢癌的有前景的工具。